Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122698512 | 12269851 | 2 | F | 201411 | 20160810 | 20160415 | 20160819 | EXP | CA-AMGEN-CANSL2016045230 | AMGEN | 63.00 | YR | A | F | Y | 0.00000 | 20160818 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122698512 | 12269851 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG/ML, Q6MO | U | 125320 | SOLUTION FOR INJECTION | ||||||||
| 122698512 | 12269851 | 2 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Unknown | 0 | |||||||||||
| 122698512 | 12269851 | 3 | C | VITAMINE | 2 | Unknown | 0 | ||||||||||||
| 122698512 | 12269851 | 4 | C | CALCIUM | CALCIUM | 1 | Unknown | 500 UNK, BID | 0 | BID | |||||||||
| 122698512 | 12269851 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 10000 IU, QWK | 0 | 10000 | IU | /wk | |||||||
| 122698512 | 12269851 | 6 | C | CELEBREX | CELECOXIB | 1 | Unknown | 0 | |||||||||||
| 122698512 | 12269851 | 7 | C | FORXIGA | DAPAGLIFLOZIN | 1 | Unknown | 0 | |||||||||||
| 122698512 | 12269851 | 8 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 0 | |||||||||||
| 122698512 | 12269851 | 9 | C | GLYBURIDE. | GLYBURIDE | 1 | Unknown | 0 | |||||||||||
| 122698512 | 12269851 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 122698512 | 12269851 | 11 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122698512 | 12269851 | 1 | Osteoporosis postmenopausal |
| 122698512 | 12269851 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122698512 | 12269851 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122698512 | 12269851 | Arthralgia | |
| 122698512 | 12269851 | Bone pain | |
| 122698512 | 12269851 | Cervical vertebral fracture | |
| 122698512 | 12269851 | Lip discolouration | |
| 122698512 | 12269851 | Musculoskeletal chest pain | |
| 122698512 | 12269851 | Oral mucosal discolouration | |
| 122698512 | 12269851 | Pain | |
| 122698512 | 12269851 | Pain in extremity | |
| 122698512 | 12269851 | Respiratory disorder | |
| 122698512 | 12269851 | Upper limb fracture | |
| 122698512 | 12269851 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122698512 | 12269851 | 1 | 201411 | 0 |